s6y

CALYPTE BIOMEDICAL CORP

CIK
899426
Industry
Laboratory Analytical Instruments

Financials 72

  1. 10-K Annual Report for period ending Dec 31, 2012
  2. 10-Q Quarterly Report for period ending Sep 30, 2012
  3. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2012
  4. 10-Q Quarterly Report for period ending Jun 30, 2012
  5. 10-Q Quarterly Report for period ending Mar 31, 2012
  6. 10-K Annual Report for period ending Dec 31, 2011
  7. 10-Q Quarterly Report for period ending Sep 30, 2011
  8. 10-Q/A Quarterly Report for period ending Jun 30, 2011
  9. 10-Q Quarterly Report for period ending Jun 30, 2011
  10. 10-K/A Annual Report for period ending Dec 31, 2010

All 72 financials filings

News 92

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 92 news filings

Ownership 138

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. SC 13G/A Major Shareholders
  8. SC 13G/A Major Shareholders
  9. 3 Initial statement of beneficial ownership of securities
  10. SC 13G/A Major Shareholders

All 138 ownership filings

Prospectus 79

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. RW Registration Withdrawal Request
  6. RW Registration Withdrawal Request
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. S-3 Registration statement for specified transactions by certain issuers

All 79 prospectus filings

Proxies 28

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 28 proxies filings

Other 89

  1. REVOKED
  2. UPLOAD Letter (PDF)
  3. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  4. UPLOAD Letter (PDF)
  5. NTN 10K
  6. UPLOAD Letter (PDF)
  7. UPLOAD Letter (PDF)
  8. CT ORDER Order Granting Confidential Treatment
  9. UPLOAD Letter (PDF)
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 89 other filings